GLENMEDE TRUST CO NA – Halozyme Therapeutics, Inc. Transaction History
GLENMEDE TRUST CO NA portfolio value:
$15.20M
portfolio value
GLENMEDE TRUST CO NA quarter portfolio value change:
-10.14%
quarter
Halozyme Therapeutics, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -10.80% | -46.58K shares | -3.76M | $39.54 | 384.59K |
| Q2 2022 | share | Decrease | -9.87% | -47.24K shares | -108K | $44 | 431.18K |
| Q1 2022 | share | Increase | 0.00% | 478.42K shares | 19.07M | $39.88 | 478.42K |
| Q4 2020 | share | Decrease | -100.00% | -241 shares | -6K | $42.71 | 0 |
| Q3 2020 | share | Increase | +61.74% | 92 shares | 3K | $26.28 | 241 |
| Q2 2020 | share | Increase | 0.00% | 149 shares | 3K | $26.81 | 149 |
| Q4 2019 | share | Decrease | -100.00% | -200 shares | -3K | $17.73 | 0 |
| Q3 2019 | share | 0.00% | 0 shares | 0 | $15.51 | 200 | |
| Q2 2019 | share | 0.00% | 0 shares | 0 | $17.18 | 200 | |
| Q1 2019 | share | 0.00% | 0 shares | 1K | $16.1 | 200 | |
| Q4 2018 | share | Increase | 0.00% | 200 shares | 2K | $14.63 | 200 |
| Q2 2018 | share | Decrease | -100.00% | -635 shares | -12K | $16.87 | 0 |
| Q1 2018 | share | 0.00% | 0 shares | 0 | $19.59 | 635 | |
| Q4 2017 | share | Increase | 0.00% | 635 shares | 12K | $20.26 | 635 |
| Q3 2016 | share | Decrease | -100.00% | -173 shares | -1K | $12.08 | 0 |
| Q2 2016 | share | 0.00% | 0 shares | 0 | $8.63 | 173 | |
| Q1 2016 | share | Increase | 0.00% | 173 shares | 1K | $9.47 | 173 |